Annual Meeting Late-Breaking Oral Abstract Session to Highlight Research on Blood Donor Sex, COVID-19, Platelets

September 20, 2021

The AABB Annual Meeting is known as the preeminent forum to present practice-changing research in transfusion medicine and biotherapies. The Late-Breaking Oral Abstract Session – returning to the annual meeting for the second time – provides an important opportunity for investigators to present novel and high-impact research that was not completed at the time of the general submission deadline.

Each of the abstracts selected for this year’s session addresses an emergent topic in transfusion medicine, such as patient outcomes based on blood donor sex and platelet bacterial detection. In addition to their impact within the field, several abstracts, such as those related to COVID-19 vaccination, also demonstrate the critical role of transfusion medicine research in supporting the pandemic response and other public health goals. 

“There was no shortage of interesting and innovative research for the Committee to consider, but these abstracts address some of the most pressing questions facing our community,” said Melissa M. Cushing, MD, Selection of Abstracts Committee chair, “I look forward to this session and encourage all attendees to join me in attending.”

The Late-Breaking Oral Abstract Session will take place at 7:15 p.m. ET on Monday, Oct. 18. Additional information about each abstract is available below:

An Innovative Trial Assessing Donor Sex on Recipient Survival (iTADS)
Presented by Michaël Chassé, MD, PhD, from Centre Hospitalier de l’Université de Montréal

Estimating COVID-19 Vaccine Effectiveness Using Repeat Blood Donor Data
Presented by Eduard Grebe, PhD, from Vitalant Research Institute

Large-Volume, Delayed Sampling of Platelets Causes Increase in False-Positive Bacterial Detection Rate
Presented by Eric Senaldi, MD, from New York Blood Center

Response to COVID-19 Vaccination in Lymphopenic Apheresis Platelet Donors
Presented by Renée Bazin, PhD, from Héma-Québec

Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against Sars-CoV2 Variants
Presented by Clara Di Germanio, PhD, from Vitalant Research Institute